{"public_id":"co_d2c521847f14679f365a6d7b59aec607","status":"active","merged_into_public_id":null,"resolved_public_id":"co_d2c521847f14679f365a6d7b59aec607","name":"serum biomarkers","description":"Blood-based laboratory markers measured to track disease status and treatment effects.","aliases":[],"types":["outcome measure"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":5867328,"title":"High-volume hemofiltration plus hemoperfusion for hyperlipidemic severe acute pancreatitis: a controlled pilot study","citation_count":41,"url":"https://sah.borca.ai/papers/5867328"}],"claims":[{"public_id":"cl_4e70f46dcb7e35b942407e9558785cc3","text":"Adding high-volume hemofiltration plus hemoperfusion to conventional treatment improved clinical severity scores, vital signs, pancreatic and renal biomarkers, and inflammatory cytokines in hyperlipidemic severe acute pancreatitis.","corpus_id":5867328,"url":"https://sah.borca.ai/claims/cl_4e70f46dcb7e35b942407e9558785cc3"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_d2c521847f14679f365a6d7b59aec607","url":"https://sah.borca.ai/concepts/co_d2c521847f14679f365a6d7b59aec607"}